New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
17:20 EDTMGNXMacroGenics IND MGD007 cleared by FDA to start enrolling patients
MacroGenics announced that its investigational new drug, or IND, for MGD007 has been cleared by the FDA to proceed with the phase 1 human clinical trial for this drug candidate. MGD007 is a Dual-Affinity Re-Targeting protein being developed for the treatment of colorectal cancer. MacroGenics will receive a $5M milestone payment from Servier, France's largest privately-held pharmaceutical company, triggered by the IND clearance.
News For MGNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
09:22 EDTMGNXMacroGenics added to Focus List at Roth Capital
Subscribe for More Information
December 7, 2014
14:10 EDTMGNXAmerican Society of Hematology to hold a meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use